Show simple item record

dc.contributor.authorAsamblea Mundial de la Salud, 32
dc.date.accessioned2015-11-21T01:20:36Z
dc.date.available2015-11-21T01:20:36Z
dc.date.issued1979
dc.identifier.govdocA32/B/Conf.Paper No.14
dc.identifier.govdocA32/B/Conf.Paper No.14 Add.1
dc.identifier.govdocA32/B/Conf.Paper No.14 Add.2
dc.identifier.govdocA32/B/Conf.Paper No.14 Add.2 Corr.1
dc.identifier.urihttps://apps.who.int/iris/handle/10665/196456
dc.description(‎Punto 2.7.2 del orden del día)‎en_US
dc.language.isoesen_US
dc.publisherOrganización Mundial de la Saluden_US
dc.subjectPharmaceutical productsen_US
dc.subjectEssential medicinesen_US
dc.subject.meshPharmaceutical Preparationsen_US
dc.subject.meshDrugs, Essentialen_US
dc.subject.meshDrug and Narcotic Controlen_US
dc.subject.meshProgram Developmenten_US
dc.subject.meshProgram Evaluationen_US
dc.subject.meshDrug Evaluationen_US
dc.subject.meshDrug Industryen_US
dc.subject.meshNational Health Programsen_US
dc.titlePrograma de acción sobre medicamentos esenciales (‎proyecto de resolución presentado por las delegaciones de Cuba, Mozambique, Noruega y Yugoslavia)‎en_US
dc.typeGoverning body documentsen_US
dc.subject.meshqualifierprevention and controlen_US


Files in this item

Thumbnail

This item appears in the following Collection(‎s)‎

Show simple item record